Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort Study

IF 6.6 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Alimentary Pharmacology & Therapeutics Pub Date : 2025-03-04 DOI:10.1111/apt.70073

Nicolas Richard, Aurélien Amiot, Philippe Seksik, Romain Altwegg, David Laharie, Lucine Vuitton, Maria Nachury, Guillaume Bouguen, Stéphane Nancey, Cyrielle Gilletta, Cléa Rouilon, Benoît Coffin, Matthieu Allez, Anthony Buisson, Catherine Le Berre, Mathieu Uzzan, Ludovic Caillo, Anne-Laure Pelletier, Laurent Peyrin-Biroulet, Mathurin Fumery

引用次数: 0

Abstract

Real-world effectiveness and safety of upadacitinib in patients with Crohn's disease (CD) remain unclear.

Abstract Image

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Alimentary Pharmacology & Therapeutics 医学-胃肠肝病学

CiteScore

15.60

自引率

7.90%

发文量

527

审稿时长

3-6 weeks

期刊介绍： Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.